NCT01634100View on ClinicalTrials.gov

Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy
Interventions
DRUG

Probenecid

Probenecid

DRUG

Rifampicin

Rifampicin

DRUG

Empagliflozin

BI Drug

DRUG

Empagliflozin

BI Drug

DRUG

Rifampicin

Rifampicin

DRUG

Probenecid

Probenecid

DRUG

Empagliflozin (BI 10773)

BI Drug

Trial Locations (1)

Unknown

1245.83.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01634100 - Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid | Biotech Hunter | Biotech Hunter